Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Average Length of Rental for Repairable Vehicles: Q1 2021
The quarterly LOR summary is produced by
Mitchell
Article
The Shift in Mobility Patterns
Just two years ago, some experts predicted the
Mitchell
Article
Self-Help Tools for Providers
This article is authored by guest blogger, Mike McKinley, director of product development at Coventry, a part of Mitchell | Genex | Coventry.
Mitchell
News Release
Debbie Day named to Teach for America San Diego Regional Board
Workers' Comp
Article
Best Practices for Supporting Mental Health in Comp
There’s a heightened awareness in our industry on how psychosocial factors impact an injured employee’s recovery.
Workers' Comp
Podcast
Best Practices for Supporting Mental Health in Comp
There’s a heightened awareness in our industry on how psychosocial factors impact an injured employee’s recovery.